2022 update of the drug resistance mutations in HIV-1

Annemarie M. Wensing; Vincent Calvez; Francesca Ceccherini-Silberstein; Charlotte Charpentier; Huldrych F. Günthard; Roger Paredes; Robert W. Shafer; Douglas D. Richman

2022 update of the drug resistance mutations in HIV-1

Annemarie M. Wensing, Vincent Calvez, Francesca Ceccherini-Silberstein, Charlotte Charpentier, Huldrych F. Günthard, Roger Paredes, Robert W. Shafer, Douglas D. Richman

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

Abstract

The 2022 edition of the IAS-USA drug resistance mutations list updates the Figure last published in September 2019. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The Figure is designed to assist practitioners to identify key mutations associated with resistance to antiretroviral drugs, and therefore, in making clinical decisions regarding antiretroviral therapy.

Original language	English
Pages (from-to)	559-574
Number of pages	15
Journal	Topics in Antiviral Medicine
Volume	30
Issue number	4
Publication status	Published - 1 Oct 2022

Keywords

HIV
antiretroviral
drug resistance
TAM
therapy
mutations

Access to Document

https://www.iasusa.org/resources/hiv-drug-resistance-mutations/

Cite this

@article{5b9a43c0121841f69e1f62160f9dd9d6,

title = "2022 update of the drug resistance mutations in HIV-1",

abstract = "The 2022 edition of the IAS-USA drug resistance mutations list updates the Figure last published in September 2019. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The Figure is designed to assist practitioners to identify key mutations associated with resistance to antiretroviral drugs, and therefore, in making clinical decisions regarding antiretroviral therapy.",

keywords = "HIV, antiretroviral, drug resistance, TAM, therapy, mutations",

author = "Wensing, {Annemarie M.} and Vincent Calvez and Francesca Ceccherini-Silberstein and Charlotte Charpentier and G{\"u}nthard, {Huldrych F.} and Roger Paredes and Shafer, {Robert W.} and Richman, {Douglas D.}",

year = "2022",

month = oct,

day = "1",

language = "English",

volume = "30",

pages = "559--574",

journal = "Topics in Antiviral Medicine",

issn = "2161-5861",

publisher = "International Antiviral Society",

number = "4",

}

TY - JOUR

T1 - 2022 update of the drug resistance mutations in HIV-1

AU - Wensing, Annemarie M.

AU - Calvez, Vincent

AU - Ceccherini-Silberstein, Francesca

AU - Charpentier, Charlotte

AU - Günthard, Huldrych F.

AU - Paredes, Roger

AU - Shafer, Robert W.

AU - Richman, Douglas D.

PY - 2022/10/1

Y1 - 2022/10/1

N2 - The 2022 edition of the IAS-USA drug resistance mutations list updates the Figure last published in September 2019. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The Figure is designed to assist practitioners to identify key mutations associated with resistance to antiretroviral drugs, and therefore, in making clinical decisions regarding antiretroviral therapy.

AB - The 2022 edition of the IAS-USA drug resistance mutations list updates the Figure last published in September 2019. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The Figure is designed to assist practitioners to identify key mutations associated with resistance to antiretroviral drugs, and therefore, in making clinical decisions regarding antiretroviral therapy.

KW - HIV

KW - antiretroviral

KW - drug resistance

KW - TAM

KW - therapy

KW - mutations

UR - http://www.scopus.com/inward/record.url?scp=85141970655&partnerID=8YFLogxK

M3 - Article

C2 - 36375130

AN - SCOPUS:85141970655

SN - 2161-5861

VL - 30

SP - 559

EP - 574

JO - Topics in Antiviral Medicine

JF - Topics in Antiviral Medicine

IS - 4

ER -

2022 update of the drug resistance mutations in HIV-1

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this